Birte Kulemann
- Surgery top 5%
- Oncology top 5%
- Pulmonary and Respiratory Medicine top 5%
- Cancer Research top 10%
- Molecular Biology
- Co-authors
- Jens HoeppnerUlrich T. HoptGoran MarjanovićTorben GlatzFrank MakowiecPeter BronsertOlivia SickTobias Keck
- Topics
- Pancreatic and Hepatic Oncology Research (24 papers)Esophageal Cancer Research and Treatment (13 papers)Cancer Cells and Metastasis (13 papers)
- Partner nations
- GermanyUnited StatesSwitzerland
In The Last Decade
Birte Kulemann
57 papers receiving 1.4k citations
Hit Papers
Peers
Comparison fields: 5 of 86
- Surgery 737
- Oncology 724
- Pulmonary and Respiratory Medicine 488
- Cancer Research 302
- Molecular Biology 217
Countries citing papers authored by Birte Kulemann
This map shows the geographic impact of Birte Kulemann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Birte Kulemann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Birte Kulemann more than expected).
Fields of papers citing papers by Birte Kulemann
This network shows the impact of papers produced by Birte Kulemann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Birte Kulemann. The network helps show where Birte Kulemann may publish in the future.
Co-authorship network of co-authors of Birte Kulemann
This figure shows the co-authorship network connecting the top 25 collaborators of Birte Kulemann. A scholar is included among the top collaborators of Birte Kulemann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Birte Kulemann. Birte Kulemann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | Prospective randomized multicenter phase III trial comparing perioperative chemotherapy (FLOT protocol) to neoadjuvant chemoradiation (CROSS protocol) in patients with adenocarcinoma of the esophagus (ESOPEC trial).breakdown → | 37 |
| 2 | 8 | |
| 3 | 1 | |
| 4 | 5 | |
| 5 | 3 | |
| 6 | 14 | |
| 7 | 34 | |
| 8 | 37 | |
| 9 | 17 | |
| 10 | 21 | |
| 11 | 5 | |
| 12 | 40 | |
| 13 | 37 | |
| 14 | 82 | |
| 15 | 10 | |
| 16 | 110 | |
| 17 | 3 | |
| 18 | 2 | |
| 19 | 29 | |
| 20 | 5 |
About Birte Kulemann
Birte Kulemann is a scholar working on Oncology, Surgery and Gastroenterology, having authored 58 papers that have together received 1.4k indexed citations. Recurring topics across this work include Pancreatic and Hepatic Oncology Research (24 papers), Esophageal Cancer Research and Treatment (13 papers) and Cancer Cells and Metastasis (13 papers). The work is most often cited by research in Oncology (724 citations), Gastroenterology (115 citations) and Cancer Research (302 citations). Birte Kulemann has collaborated with scholars based in Germany, United States and Switzerland. Frequent co-authors include Jens Hoeppner, Ulrich T. Hopt, Goran Marjanović, Torben Glatz, Frank Makowiec, Peter Bronsert, Olivia Sick, Tobias Keck, Ulrich F. Wellner and Sarah P. Thayer. Their work appears in journals such as Journal of Clinical Oncology, Gastroenterology and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.